These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1482259)

  • 1. [Increase of erythrocyte aggregation in hypertensive men with dyslipidemia].
    Razavian SM; Del-Pino M; Duché C; Simon A; Levenson J
    Arch Mal Coeur Vaiss; 1992 Aug; 85(8):1197-9. PubMed ID: 1482259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Increase of erythrocyte disaggregation shear rate in arterial hypertension].
    Razavian SM; Del-Pino M; Chabanel A; Simon A; Levenson J
    Arch Mal Coeur Vaiss; 1991 Aug; 84(8):1081-3. PubMed ID: 1953253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hemorheological alterations in hypertensive patients].
    Foresto P; D'Arrigo M; Filippini F; Gallo R; Barberena L; Racca L; Valverde J; Rasia RJ
    Medicina (B Aires); 2005; 65(2):121-5. PubMed ID: 16075805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of sialic acid on erythrocyte aggregation in hypercholesterolemia.
    Hadengue A; Razavian SM; Del-Pino M; Simon A; Levenson J
    Thromb Haemost; 1996 Dec; 76(6):944-9. PubMed ID: 8972015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemorheological abnormalities in arterial hypertension and their relation to cardiac hypertrophy.
    Zannad F; Voisin P; Brunotte F; Bruntz JF; Stoltz JF; Gilgenkrantz JM
    J Hypertens; 1988 Apr; 6(4):293-7. PubMed ID: 2967860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Erythrocyte aggregation in vascular disease. Influence++ of hypertension].
    Chabanel A; Slama G; Samama M
    J Mal Vasc; 1991; 16(3):271-4. PubMed ID: 1940653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relation between the erythrocyte nitric oxide and hemorheological parameters.
    Carvalho FA; Maria AV; Braz Nogueira JM; Guerra J; Martins-Silva J; Saldanha C
    Clin Hemorheol Microcirc; 2006; 35(1-2):341-7. PubMed ID: 16899954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Beneficial effects of statins and angiotensin converting enzyme inhibitors on aggregability of red blood cells in hypertensive patients].
    Korbut RA; Guzik B; Adamek-Guzik T; Korbut R
    Folia Med Cracov; 2006; 47(1-4):37-49. PubMed ID: 18038611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of fibrinogen and lipoproteins to plasma viscosity in hypercholesterolemia and hypertriglyceridemia: evaluation by selective depletion of low-density lipoproteins or fibrinogen.
    Otto C; Richter WO; Schwandt P
    Metabolism; 2000 Jun; 49(6):810-3. PubMed ID: 10877212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red blood cell (RBC) deformability, RBC aggregability and tissue oxygenation in hypertension.
    Cicco G; Pirrelli A
    Clin Hemorheol Microcirc; 1999; 21(3-4):169-77. PubMed ID: 10711739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemorheological disturbances in hypertensive type 2 diabetic patients--influence of antihypertensive therapy.
    Kearney-Schwartz A; Virion JM; Stoltz JF; Drouin P; Zannad F
    Fundam Clin Pharmacol; 2007 Aug; 21(4):387-96. PubMed ID: 17635177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term LDL apheresis does not stably improve hemorheology in hypercholesterolemic patients with coronary artery disease.
    Pusl T; Broedl UC; Parhofer KG; Otto C
    Clin Hemorheol Microcirc; 2009; 41(2):137-42. PubMed ID: 19252236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between aortic stiffness and cardiovascular risk factors in a population of normotensives, white-coat normotensives, white-coat hypertensives, sustained hypertensives and diabetic patients.
    Silva JA; Barbosa L; Bertoquini S; Maldonado J; Polónia J
    Rev Port Cardiol; 2004 Dec; 23(12):1533-47. PubMed ID: 15732656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheological properties of blood and parameters of platelets aggregation in arterial hypertension.
    Konstantinova E; Ivanova L; Tolstaya T; Mironova E
    Clin Hemorheol Microcirc; 2006; 35(1-2):135-8. PubMed ID: 16899917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Increase of erythrocyte aggregation in retinal vein occlusion].
    Glacet-Bernard A; Chabanel A; Coscas G; Lelong F; Samama M
    J Fr Ophtalmol; 1990; 13(10):500-5. PubMed ID: 2081840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood lipid spectrum in hypertensive patients and normotensive subjects living in the Khanty-Mansiysk region].
    Mikhaĭlova IM; Gapon LI; Belousov VV; Startseva ON; Alekseeva SV
    Ter Arkh; 2009; 81(9):17-9. PubMed ID: 19827646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in erythrocyte disaggregation shear stress in hypertension.
    Razavian SM; Del Pino M; Simon A; Levenson J
    Hypertension; 1992 Aug; 20(2):247-52. PubMed ID: 1639467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and association with diabetes and obesity of lipid phenotypes among the hypertensive Chinese rural adults.
    Zhang X; Sun Z; Zhang D; Zheng L; Li J; Liu S; Xu C; Li J; Hu D; Sun Y
    Heart Lung; 2009; 38(1):17-24. PubMed ID: 19150527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormalities in thrombogenic and rheologic factors in Nigerian hypertensive patients.
    Ogunlade OA; Fasanmade AA
    Afr J Med Med Sci; 2001 Dec; 30(4):291-4. PubMed ID: 14510106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic hemorheological effects of the calcium antagonist nilvadipine in essential hypertension.
    Tsuda Y; Satoh K; Kitadai M; Izumi Y; Takahashi T
    Arzneimittelforschung; 1997 Aug; 47(8):900-4. PubMed ID: 9296274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.